Title : [Oral anticoagulation and pharmacogenetics: importance in the clinical setting].

Pub. Date : 2007 Sep 12

PMID : 17955831






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Single nucleotide polymorphisms (SNPs) in genes encoding cytochrome P450 enzyme 2C9 (CYP2C9) and Vitamin K epoxide reductase subunit I (VKORC1) make a significant contribution to the inter-individual variability in the maintenance dose of vitamin K antagonists (warfarin, acenocoumarol, phenprocoumon). Vitamin K cytochrome P450 family 2 subfamily C member 9 Homo sapiens
2 Single nucleotide polymorphisms (SNPs) in genes encoding cytochrome P450 enzyme 2C9 (CYP2C9) and Vitamin K epoxide reductase subunit I (VKORC1) make a significant contribution to the inter-individual variability in the maintenance dose of vitamin K antagonists (warfarin, acenocoumarol, phenprocoumon). Vitamin K cytochrome P450 family 2 subfamily C member 9 Homo sapiens
3 CYP2C9 and VKORC1 account for up to half the variability in vitamin K antagonists requirements and incorporating genotying data for these two genes into dosing algorithms could lead to a safer anticoagulation therapy. Vitamin K cytochrome P450 family 2 subfamily C member 9 Homo sapiens